Institut Du Cerveau Et De La Moelle Epiniere
- Address
- 47 Boulevard De L Hopital, 75013 Paris, France
Institut Du Cerveau Et De La Moelle Epiniere - Neurological Disease Research Center
The Institut Du Cerveau Et De La Moelle Epiniere (Brain and Spine Institute) is a distinguished research center dedicated to advancing the understanding and treatment of complex neurological disorders. The institute specializes in innovative therapeutic approaches and advanced neuroimaging studies targeting degenerative and inflammatory conditions of the brain and spinal cord.
- Gene therapy and novel biological interventions for Huntington's disease, including striatal administration of experimental therapeutics
- Remyelination processes and myelin repair mechanisms in Multiple Sclerosis using advanced PET-MR imaging
- Neuroinflammation research and its contribution to disease progression and recovery in central nervous system disorders
The center conducts cutting-edge early-phase clinical trials investigating neurodegenerative diseases and demyelinating disorders. Their research portfolio includes phase I/II studies evaluating the safety and efficacy of direct brain administration of experimental therapies, as well as sophisticated longitudinal imaging studies to characterize individual patterns of myelin repair and neuroinflammatory processes in patients with chronic neurological conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Institut Du Cerveau Et De La Moelle Epiniere
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2/3, Double-Blind, Placebo-Controlled Study of BHV-8000 in Participants with Early Parkinson’s Disease | Biohaven Therapeutics Ltd. | Phase IV | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Adeno-Associated Viral Vector Serotype Rh10 Containing The Human Cholesterol 24-Hydroxylase Gene | 1 | Unknown | 2024-11-07 | 2024-11-07 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.